Perrigo Ready To Launch OTC Nasonex In 2022

As Company Completes Divestiture Of Latin American Business

 
• By Akriti Seth
  
Cough Cold
Perrigo delivers a healthy Q4 FY21 on the back of a strong rebound in demand for cough/cold products • Source: Alamy

More from Products

More from Generics Bulletin